Gelesis Closes $16M Series A to Fund its Obesity Program
With plans to target the ballooning obesity market, Gelesis Inc. raised $16 million in its Series A financing.
The Boston-based company has remained under the radar since its founding in 2006, and Eric Elenko, interim vice president of business development, declined to comment on its technology or pipeline.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter